Hyku
Lexington, KY
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins. The Hyku platform identifies molecules that covalently bind non-cysteine amino acids to aid in the creation of innovative medicines that can address present issues with a variety of disease targets, such as selectivity, druggability, and resistance.
hykubiosciences.comCompany Details
Founded
- 2021
Employees
- Between 10 - 50 employees
Raised
- $56,000,000
Headquarters Location
- Lexington, KY
Public
- No
Acquired
- No
CEO
- N/A
Company Collections
These are collections Hyku is a part of. Click on the collection name to view similar companies.